Assessment of Adverse drug reactions, drug-drug Interactions and medication adherence outcomes among elderly HIV seropositive patients in comparison with young HIV seropositive patients undergoing highly active antiretroviral therapy.
Not Applicable
- Conditions
- Health Condition 1: null- HIV seropositive patients
- Registration Number
- CTRI/2018/01/011169
- Lead Sponsor
- Kasturba medical college Kasturba Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HIV seropositive patients (HIV-SPP) patients above 18 years of age undergoing Highly active antiretroviral therapy (HAART)
treatment will be included.
Exclusion Criteria
HIV-SPP who were not on HAART, with chronic-renal-disease, chronic-kidney-disease,
rheumatoid-arthritis, cancer, on traditional alternative medicines, pregnant women, who refused
for medication adherence outcome assessment will be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADRs and CS-DDIs to HAART will be assessed and compared between both groups.Timepoint: Clinical data collection during the hospital stay <br/ ><br>and/or follow up during the study period.
- Secondary Outcome Measures
Name Time Method Medication adherence to HAART will be assessed using AIDS Clinical Trail Group (ACTG) adherence questionnaire.Timepoint: Clinical data collection during the hospital stay <br/ ><br>and/or follow up during the study period.